Patent details

EP2345668 Title: SCLEROSTIN EPITOPES

Basic Information

Publication number:
EP2345668
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP100143601
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SCLEROSTIN EPITOPES
French Title of Invention:
Epitopes de la sclérostine
German Title of Invention:
SCLEROSTIN EPITOPE
SPC Number:

Dates

Filing date:
28/04/2006
Grant date:
22/09/2021
EP Publication Date:
20/07/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/09/2021
EP B1 Publication Date:
22/09/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/04/2022
Expiration date:
28/04/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/09/2021
 
 

Name:
Amgen, Inc.
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Name:
UCB Pharma, S.A.
Address:
Allée de la Recherche 60, 1070 Bruxelles, Belgium (BE)

Inventor

1

Name:
Hoffmann, Kelly Sue
Address:
United States (US)

2

Name:
Latham, John
Address:
United States (US)

3

Name:
Robinson, Martyn Kim
Address:
United Kingdom (GB)

4

Name:
Paszty, Christopher
Address:
United States (US)

5

Name:
Lawson, Alastair
Address:
United Kingdom (GB)

6

Name:
Winters, Aaron George
Address:
United States (US)

7

Name:
Winkler, David
Address:
United States (US)

8

Name:
Henry, Alistair James
Address:
United Kingdom (GB)

9

Name:
Lu, Hsieng Sen
Address:
United States (US)

Priority

1

Priority Number:
677583 P
Priority Date:
03/05/2005
Priority Country:
United States (US)

2

Priority Number:
776847 P
Priority Date:
24/02/2006
Priority Country:
United States (US)

3

Priority Number:
782244 P
Priority Date:
13/03/2006
Priority Country:
United States (US)

4

Priority Number:
792645 P
Priority Date:
17/04/2006
Priority Country:
United States (US)

5

Priority Number:
410540
Priority Date:
25/04/2006
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/22; A61K 39/00; C12N 15/63; A61P 15/12; C07K 14/51; A61P 19/00; A61P 19/08; A61P 19/10; A61P 43/00;

Publication

European Patent Bulletin

1

Issue number:
202138
Publication date:
22/09/2021
Description:
Grant (B1)

2

Issue number:
202327
Publication date:
05/07/2023
Description:
Termination of the opposition

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages